Unlocking cellular potential for next-gen biomanufacturing

Silvia Bio accelerates biomanufacturing by pinpointing bottlenecks in mammalian cells, and delivering precision media solutions that bring predictability to your bioprocess.

Our solution

The Silvia Bio Platform rapidly profiles cellular performance in manufacturing processes, and implements potent media additives that boost product titre and critical quality attributes

Identify

Proprietary cell profiling technology that determines critical cell parameters and processes constraining the yield and quality of biomanufactured products.

Fix

Precision media additives specifically formulated to overcome production bottlenecks identified by our cell profiling platform.

Service Platform

Silvia Bio's Cell Profiling

Understand the precise manufacturing related bottlenecks constraining cell performance using our cell profiling platform.

Bespoke fingerprint of cell performance
Rapid turnaround times (<4 weeks)
High success rate
Simple to interpret data
Manufacturing relevant insights
Licensable Products

Licensable Media Additives

Improve production with highly effective small molecules that significantly improve cell productivity through specifically targeting rate-limiting process constraints.

Substantial increases in cell performance
Specifically formulated to improve titre and quality
Bioreactor compatible additives
Low cost of goods
Easy to implement
Our advantage

Why work with Silvia Bio

80%
Quicker
Cell profiling data in as little as 2 weeks, substantially quicker than omics studies
Manufacturing relevant insights
Our profiling technology focuses on cell processes with direction implications on manufacturing
2x
Higher Cell Productivity
Significantly increase cell productivity with Silvia Bio media additives
Success stories

Case studies from previous partners

BioPharma
January 7, 2026
Improving monoclonal antibody production in CHO cells
BioPharma
January 7, 2026
Identifying universal bottlenecks in CHO cell clones and pools for informed host cell line development
Who we are

Meet the team

Edward Curry
CEO

Lorem ipsum dolor sit amet consectetur. Lacus facilisis id molestie ipsum egestas quam. Aenean tincidunt massa porttitor vitae. Nec pharetra viverra enim senectus viverra tincidunt. Lacus ut ac morbi purus enim tincidunt dolor in egestas.

Melinda Pohle
CSO

Lorem ipsum dolor sit amet consectetur. Lacus facilisis id molestie ipsum egestas quam. Aenean tincidunt massa porttitor vitae. Nec pharetra viverra enim senectus viverra tincidunt. Lacus ut ac morbi purus enim tincidunt dolor in egestas.

Adam Brown
Scientific Advisor

Lorem ipsum dolor sit amet consectetur. Lacus facilisis id molestie ipsum egestas quam. Aenean tincidunt massa porttitor vitae. Nec pharetra viverra enim senectus viverra tincidunt. Lacus ut ac morbi purus enim tincidunt dolor in egestas.

David James
Scientific Advisor

Lorem ipsum dolor sit amet consectetur. Lacus facilisis id molestie ipsum egestas quam. Aenean tincidunt massa porttitor vitae. Nec pharetra viverra enim senectus viverra tincidunt. Lacus ut ac morbi purus enim tincidunt dolor in egestas.

Andy Lewin
Commercial Advisor

Andy Lewin brings deep expertise in business development within the biopharmaceutical sector. He previously held senior leadership roles as Vice President of Business Development at Oxford Biomedica and AGC Biologics, where he drove strategic partnerships and growth initiatives across global markets.

Joanna Smart
Strategy Advisor

Joanna Smart is a seasoned strategic advisor with extensive leadership experience in the life sciences sector. Formerly a CEO and Non-Executive Chair, she has played a pivotal role in shaping innovative healthcare ventures. Joanna also supported the early-stage life sciences portfolio at BGF, bringing deep expertise in growth strategy and investment.

Edward Curry
CEO

Lorem ipsum dolor sit amet consectetur. Lacus facilisis id molestie ipsum egestas quam. Aenean tincidunt massa porttitor vitae. Nec pharetra viverra enim senectus viverra tincidunt. Lacus ut ac morbi purus enim tincidunt dolor in egestas.

Melinda Pohle
CSO

Lorem ipsum dolor sit amet consectetur. Lacus facilisis id molestie ipsum egestas quam. Aenean tincidunt massa porttitor vitae. Nec pharetra viverra enim senectus viverra tincidunt. Lacus ut ac morbi purus enim tincidunt dolor in egestas.

Adam Brown
Scientific Advisor

Lorem ipsum dolor sit amet consectetur. Lacus facilisis id molestie ipsum egestas quam. Aenean tincidunt massa porttitor vitae. Nec pharetra viverra enim senectus viverra tincidunt. Lacus ut ac morbi purus enim tincidunt dolor in egestas.

David James
Scientific Advisor

Lorem ipsum dolor sit amet consectetur. Lacus facilisis id molestie ipsum egestas quam. Aenean tincidunt massa porttitor vitae. Nec pharetra viverra enim senectus viverra tincidunt. Lacus ut ac morbi purus enim tincidunt dolor in egestas.

Andy Lewin
Commercial Advisor

Andy Lewin brings deep expertise in business development within the biopharmaceutical sector. He previously held senior leadership roles as Vice President of Business Development at Oxford Biomedica and AGC Biologics, where he drove strategic partnerships and growth initiatives across global markets.

Joanna Smart
Strategy Advisor

Joanna Smart is a seasoned strategic advisor with extensive leadership experience in the life sciences sector. Formerly a CEO and Non-Executive Chair, she has played a pivotal role in shaping innovative healthcare ventures. Joanna also supported the early-stage life sciences portfolio at BGF, bringing deep expertise in growth strategy and investment.

Updates

Keep up to date

Update
December 15, 2025
Silvia Bio presents at NG Studios x KQ Labs Demo Day
Silvia Bio presents at NG Studios x KQ Labs Demo Day
Update
December 15, 2025
Update
November 18, 2025
Silvia Bio launches early-adopter program for cell profiling
Silvia Bio launches early-adopter program for cell profiling
Update
November 18, 2025
Update
August 19, 2025
SilViA Bio has officially joined the KQ Labs Life Sciences accelerator program.
SilViA Bio has officially joined the KQ Labs Life Sciences accelerator program.
Update
August 19, 2025